Navigation Links
BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries

Bloomington, Indiana (PRWEB) June 06, 2013

BioConvergence, a contract service provider for pharmaceutical and biotechnology companies, recently launched a life sciences blog that addresses industry best practices.

The blog will cover a wide range of topics including testing and development, quality assurance, production, and supply chain management and security. The breadth of topics is well-suited to the organization, according to Lesli Stasiek, Global Manager of Business Development and Marketing:

“As a contract service provider, we produce unique solutions for life sciences organizations, regardless of their size or product development stage. Beyond this, our team members have gathered to BioConvergence from a wide variety of industry firms of different sizes, and many have worked with contract firms as clients themselves. These factors have given our team a broad perspective of the best practices realm that I know our readership will find both interesting and relevant.”

In addition to the articles supplied by BioConvergence, the company’s alliance partner Modality Solutions will also be contributing regularly.

Modality Solutions employs a Transport Simulation Laboratory of their design to simulate the rigors that pharmaceutical products are exposed to during transportation. BioConvergence then offers the support testing, quality assurance, and storage services needed to accommodate recommendations for formulation improvement.

Modality’s principals add over 100 years of combined life sciences experience to the nearly 500 years represented by the BioConvergence team. BioConvergence hopes that industry professionals, regardless of role, will “take advantage of this resource and gain greater visibility to industry trends and knowledge,” according to Stasiek.

To access BioConvergence’s corporate blog and additional resources, please visit

About BioConvergence

BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain management. A women-owned and operated business headquartered in Bloomington, Indiana, BioConvergence has a team of over 50 members with nearly five centuries’ worth of combined experience in the life sciences industry. The company’s unique E-Transparency® System provides transparency and flexibility to its clients, along with superior, quality-driven outsourcing solutions. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
2. BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
3. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
4. MAX Launches "Double HELIX" in Marylands Biotechnology Corridor
5. Salimetrics Launches a Faster, More Accurate, Salivary Melatonin Assay
6. Medical Concierge Travel International launches in Tandem with Leading Medical Cost Containment Company, EME International aimed at Self-Funded and Insurance Companies
7. Puritan Medical Products Launches New Series to Tell Customer Stories
8. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
9. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
10. Elsevier Launches New Open Access Journal: Translational Proteomics
11. Project Oncology CME Series Launches on ReachMD, Offering Learners a Wide Array of Certified Oncology Activities Across an Integrated Platform
Post Your Comments:
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/25/2015)... PUNE, India , November 26, 2015 /PRNewswire/ ... The Global Biobanking Market 2016 - 2020 ... biobanks by maintaining integrity and quality in long-term ... and enabling long-term cost-effectiveness. Automation minimizes manual errors ... improves the technical efficiency. Further, it plays a ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
(Date:10/29/2015)... Minn. , Oct. 29, 2015   MedNet ... supports the entire spectrum of clinical research, is pleased ... Minnesota High Tech Association (MHTA) as one of only ... in the "Software – Small and Growing" category. The Tekne ... individuals who have shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):